Development of a Novel Reformer for Tar-free Syngas Production

AbstractA novel reformer using highly efficient heat regeneration for tar-free syngas production is developed and its performance demonstrated in a pilot-scale plant using steam gasification. Basic design parameters of the regenerative tar reformer, namely residence time and amount of oxidant are determined based on numerical results. It has been predicted that good performance could be achieved at an operation temperature about 1573K, the residence time exceeding 4sec and an oxidant addition of 12% of the syngas flow rate. The regenerative tar reformer so designed shows stable operation. Over 99% of light and heavy tars are reformed to gas in the case of 11.3% oxygen addition to syngas. Further it is seen that a reduction of oxygen consumption more than 30% compared to a conventional oxidation reformer can be achieved. The formation of a high temperature zone has a strong influence on the tar reforming efficiency

Genomic Profiling of a Case of Glioneuronal Tumor with Neuropil-like Islands

Glioneuronal tumor with neuropil-like islands (GNTNI) is a very rare subtype of glioneuronal tumor. We present a case of a 62-year-old man with GNTNI. Two adjacent lesions in the left parietal lobe were removed by left parietal craniotomy. The histological findings were glial cell proliferation and scattered rosettes consisting of synaptophysin-positive and NeuN-positive cells, leading to the diagnosis of GNTNI. Target sequencing revealed a genetic alteration similar to glioblastoma, IDH-wild type, which suggested adjuvant therapies. There are few previous reports on the treatment of this disease, and the patient should be followed carefully

Differentiated glioblastoma cells accelerate tumor progression by shaping the tumor microenvironment via CCN1-mediated macrophage infiltration

Glioblastoma (GBM) is the most lethal primary brain tumor characterized by significant cellular heterogeneity, namely tumor cells, including GBM stem-like cells (GSCs) and differentiated GBM cells (DGCs), and non-tumor cells such as endothelial cells, vascular pericytes, macrophages, and other types of immune cells. GSCs are essential to drive tumor progression, whereas the biological roles of DGCs are largely unknown. In this study, we focused on the roles of DGCs in the tumor microenvironment. To this end, we extracted DGC-specific signature genes from transcriptomic profiles of matched pairs of in vitro GSC and DGC models. By evaluating the DGC signature using single cell data, we confirmed the presence of cell subpopulations emulated by in vitro culture models within a primary tumor. The DGC signature was correlated with the mesenchymal subtype and a poor prognosis in large GBM cohorts such as The Cancer Genome Atlas and Ivy Glioblastoma Atlas Project. In silico signaling pathway analysis suggested a role of DGCs in macrophage infiltration. Consistent with in silico findings, in vitro DGC models promoted macrophage migration. In vivo, coimplantation of DGCs and GSCs reduced the survival of tumor xenograft-bearing mice and increased macrophage infiltration into tumor tissue compared with transplantation of GSCs alone. DGCs exhibited a significant increase in YAP/TAZ/TEAD activity compared with GSCs. CCN1, a transcriptional target of YAP/TAZ, was selected from the DGC signature as a candidate secreted protein involved in macrophage recruitment. In fact, CCN1 was secreted abundantly from DGCs, but not GSCs. DGCs promoted macrophage migration in vitro and macrophage infiltration into tumor tissue in vivo through secretion of CCN1. Collectively, these results demonstrate that DGCs contribute to GSC-dependent tumor progression by shaping a mesenchymal microenvironment via CCN1-mediated macrophage infiltration. This study provides new insight into the complex GBM microenvironment consisting of heterogeneous cells

Contrast-enhanced Computed Tomography-Guided Percutaneous Cryoablation of Renal Cell Carcinoma in a Renal Allograft: First Case in Asia

Nephron-sparing treatment should be offered whenever possible to avoid dialysis in allograph cases. Cryoablation is a new treatment option for treating small-sized renal cell cancer (RCCs). We report a case of RCC arising in a kidney allograft treated by cryoablation. To our knowledge, this is the first case in Asia of RCC in a renal allograft treated using cryoablation. Contrast-enhanced CT-guided percutaneous renal needle biopsy and cryoablation were used to identify the RCC, which could not be identified by other techniques. The postoperative course was uneventful. Contrast-enhanced CT also showed no recurrence or metastases at the 6-month follow-up

An FDTD Study of Errors in Magnetic Direction Finding of Lightning Due to the Presence of Conducting Structure Near the Field Measuring Station

Lightning electromagnetic fields in the presence of conducting (grounded) structure having a height of 60 m and a square cross-section of 40 m × 40 m within about 100 m of the observation point are analyzed using the 3D finite-difference time-domain (FDTD) method. Influence of the conducting structure on the two orthogonal components of magnetic field is analyzed, and resultant errors in the estimated lightning azimuth are evaluated. Influences of ground conductivity and lightning current waveshape parameters are also examined. When the azimuth vector passes through the center of conducting structure diagonally (e.g., azimuth angle is 45°) or parallel to its walls (e.g., azimuth angle is 0°), the presence of conducting structure equally influences Hx and Hy, so that Hx/Hy is the same as in the absence of structure. Therefore, no azimuth error occurs in those configurations. When the conducting structure is not located on the azimuth vector, the structure influences Hx and Hy differently, with the resultant direction finding error being greater when the structure is located closer to the observation point